Save up to 90% on Carbidopa/Levodopa with Coupons, Discount Cards & Patient Assistance Programs

Carbidopa/Levodopa is available as a 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg oral tablet.

Carbidopa/Levodopa is a dopa decarboxylase inhibitor / dopamine replacement and is used to treat the following:

• Parkinson’s disease (PD)
• Parkinsonism (conditions that cause people to have signs and symptoms of PD, including slowness, stiffness, shakiness, and imbalance)

Carbidopa/Levodopa is a combination of two medications: carbidopa and levodopa. By working together, these medications help relieve symptoms of Parkinson’s disease (PD), which occur due to low dopamine levels in the brain. Levodopa is a dopamine replacement. Levodopa travels into your brain, where it’s converted into dopamine. It helps relieve PD symptoms by restoring dopamine in your brain. Carbidopa is a dopa decarboxylase inhibitor. Dopa decarboxylase is a protein in your body that breaks down levodopa before it can travel into your brain.

By blocking this protein, carbidopa prevents levodopa from breaking down. This raises the level of levodopa in your body and allows more levodopa to travel into your brain to be converted into dopamine. Levodopa and dopamine can then reach and remain at higher levels in your brain, which enhances levodopa’s ability to relieve PD symptoms.

Carbidopa/Levodopa is typically started at 25 mg/100 mg (Carbidopa/Levodopa) by mouth 3 times per day. Your healthcare provider will slowly raise your dose until your symptoms of PD are relieved.

Carbidopa/Levodopa is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. Nonselective monoamine oxidase (MAO) inhibitors are contraindicated for use with Carbidopa/Levodopa. These inhibitors must be discontinued at least two weeks prior to initiating therapy with Carbidopa/Levodopa.

Common side effects of Carbidopa/Levodopa:

• Involuntary movements
• Nausea

Serious side effects are rare with Carbidopa/Levodopa. Contact your healthcare provider immediately if you experience any of the following.

• Neuroleptic malignant syndrome (NMS): very high fevers, confusion, irregular pulse, sweating, muscle stiffness, changes in blood pressure

The following medications may interact with Carbidopa/Levodopa:

• Symptomatic postural hypotension has occurred when carbidopa levodopa preparations were added to
• the treatment of patients receiving some antihypertensive drugs
• Concomitant therapy with selegiline and carbidopa levodopa may be associated with severe orthostatic hypotension not attributable to carbidopa levodopa alone
• There have been rare reports of adverse reactions, including hypertension and dyskinesia, resulting from the concomitant use of tricyclic antidepressants and carbidopa levodopa preparations
• Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa. In addition, the beneficial effects of levodopa in Parkinson’s disease have been reported to be reversed by phenytoin and papaverine. Patients taking these drugs with Carbidopa/Levodopa should be carefully observed for loss of therapeutic response
• Use of Carbidopa/Levodopa with dopamine-depleting agents (e.g., reserpine and tetrabenazine) or other drugs known to deplete monoamine stores is not recommended
• Carbidopa/Levodopa and iron salts or multivitamins containing iron salts should be coadministered with caution. Iron salts can form chelates with levodopa and carbidopa and consequently reduce the bioavailability of carbidopa and levodopa

Various FDA-approved generic manufacturers

There are no adequate and well-controlled studies in pregnant women and Carbidopa/Levodopa should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

• Crexont
• Duodopa
• Duopa
• Rytary
• Sinemet
• Sinemet CR